• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Anthera Pharmaceuticals Inc

+ Add to Watchlist

ANTH:US

3.2200 USD 0.0400 1.26%

As of 20:10:00 ET on 07/11/2014.

Snapshot for Anthera Pharmaceuticals Inc (ANTH)

Open: 3.1500 Day's Range: 3.1200 - 3.2600 Volume: 54,945
Previous Close: 3.1800 52wk Range: 2.5400 - 4.6000 1-Yr Rtn: -21.08%

Stock Chart for ANTH

No chart data available.
  • ANTH:US 3.2200
  • 1D
  • 1M
  • 1Y
3.1800
Interactive ANTH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANTH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.6000
Est. EPS (USD) (12/2014) -1.6500
Est. PEG Ratio -
Market Cap (M USD) 67.26
Shares Outstanding (M) 20.89
30 Day Average Volume 163,146
Price/Book (mrq) 6.0992
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANTH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ANTH

Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.

Paul F TruexPresident/CEO/FounderDebra OdinkSenior VP/CTO
Colin HislopSenior VP/Chief Medical OfcrMay LiuSenior VP:Finance & Administration
More Company Profile & Key Executives for ANTH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil